Bisphosphonates are drugs that inhibit mineralization or resorption of the bone by blocking the action of osteoclasts. Bisphosphonates are enzyme-resistant analogues of pyrophosphate, which normally inhibits mineralization in the bone. Their effect is dose dependent and they reduce the turnover of bone by inhibiting recruitment and promoting apoptosis of osteoclasts. Bisphosphonates are used to treat postmenopausal and glucocorticoid induced osteoporosis, Paget's disease of bone and malignant hypercalcemia.
The global Bisphosphonate Drug market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Bisphosphonate Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Bisphosphonate Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Bisphosphonate Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key manufacturers of Bisphosphonate Drug include Merck, Teva, Mylan, Apotex Corp, Cobalt Pharmaceuticals, Genentech, Novartis Pharmaceuticals and Sanofi-Aventis, etc. In 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes:
This report presents an overview of global market for Bisphosphonate Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Bisphosphonate Drug, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Bisphosphonate Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Bisphosphonate Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Bisphosphonate Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Bisphosphonate Drug sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Merck, Teva, Mylan, Apotex Corp, Cobalt Pharmaceuticals, Genentech, Novartis Pharmaceuticals and Sanofi-Aventis, etc.
By Company
Merck
Teva
Mylan
Apotex Corp
Cobalt Pharmaceuticals
Genentech
Novartis Pharmaceuticals
Sanofi-Aventis
Segment by Type
Alendronate
Risedronate
Zoledronic Acid
Other Bisphosphonate Drug
Segment by Application
Postmenopausal Osteoporosis
Men with Osteoporosis
Pagetās Disease
Bone Loss Caused by Cancer Treatment
Osteoporosis Imperfecta in Children
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Bisphosphonate Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Bisphosphonate Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bisphosphonate Drug sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Bisphosphonate Drug Product Introduction
1.2 Market by Type
1.2.1 Global Bisphosphonate Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Alendronate
1.2.3 Risedronate
1.2.4 Zoledronic Acid
1.2.5 Other Bisphosphonate Drug
1.3 Market by Application
1.3.1 Global Bisphosphonate Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Postmenopausal Osteoporosis
1.3.3 Men with Osteoporosis
1.3.4 Pagetās Disease
1.3.5 Bone Loss Caused by Cancer Treatment
1.3.6 Osteoporosis Imperfecta in Children
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Bisphosphonate Drug Sales Estimates and Forecasts 2018-2029
2.2 Global Bisphosphonate Drug Revenue by Region
2.2.1 Global Bisphosphonate Drug Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Bisphosphonate Drug Revenue by Region (2018-2023)
2.2.3 Global Bisphosphonate Drug Revenue by Region (2024-2029)
2.2.4 Global Bisphosphonate Drug Revenue Market Share by Region (2018-2029)
2.3 Global Bisphosphonate Drug Sales Estimates and Forecasts 2018-2029
2.4 Global Bisphosphonate Drug Sales by Region
2.4.1 Global Bisphosphonate Drug Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Bisphosphonate Drug Sales by Region (2018-2023)
2.4.3 Global Bisphosphonate Drug Sales by Region (2024-2029)
2.4.4 Global Bisphosphonate Drug Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Bisphosphonate Drug Sales by Manufacturers
3.1.1 Global Bisphosphonate Drug Sales by Manufacturers (2018-2023)
3.1.2 Global Bisphosphonate Drug Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Bisphosphonate Drug in 2022
3.2 Global Bisphosphonate Drug Revenue by Manufacturers
3.2.1 Global Bisphosphonate Drug Revenue by Manufacturers (2018-2023)
3.2.2 Global Bisphosphonate Drug Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Bisphosphonate Drug Revenue in 2022
3.3 Global Key Players of Bisphosphonate Drug, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Bisphosphonate Drug Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Bisphosphonate Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Bisphosphonate Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Bisphosphonate Drug, Product Offered and Application
3.8 Global Key Manufacturers of Bisphosphonate Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Bisphosphonate Drug Sales by Type
4.1.1 Global Bisphosphonate Drug Historical Sales by Type (2018-2023)
4.1.2 Global Bisphosphonate Drug Forecasted Sales by Type (2024-2029)
4.1.3 Global Bisphosphonate Drug Sales Market Share by Type (2018-2029)
4.2 Global Bisphosphonate Drug Revenue by Type
4.2.1 Global Bisphosphonate Drug Historical Revenue by Type (2018-2023)
4.2.2 Global Bisphosphonate Drug Forecasted Revenue by Type (2024-2029)
4.2.3 Global Bisphosphonate Drug Revenue Market Share by Type (2018-2029)
4.3 Global Bisphosphonate Drug Price by Type
4.3.1 Global Bisphosphonate Drug Price by Type (2018-2023)
4.3.2 Global Bisphosphonate Drug Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Bisphosphonate Drug Sales by Application
5.1.1 Global Bisphosphonate Drug Historical Sales by Application (2018-2023)
5.1.2 Global Bisphosphonate Drug Forecasted Sales by Application (2024-2029)
5.1.3 Global Bisphosphonate Drug Sales Market Share by Application (2018-2029)
5.2 Global Bisphosphonate Drug Revenue by Application
5.2.1 Global Bisphosphonate Drug Historical Revenue by Application (2018-2023)
5.2.2 Global Bisphosphonate Drug Forecasted Revenue by Application (2024-2029)
5.2.3 Global Bisphosphonate Drug Revenue Market Share by Application (2018-2029)
5.3 Global Bisphosphonate Drug Price by Application
5.3.1 Global Bisphosphonate Drug Price by Application (2018-2023)
5.3.2 Global Bisphosphonate Drug Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Bisphosphonate Drug Market Size by Type
6.1.1 US & Canada Bisphosphonate Drug Sales by Type (2018-2029)
6.1.2 US & Canada Bisphosphonate Drug Revenue by Type (2018-2029)
6.2 US & Canada Bisphosphonate Drug Market Size by Application
6.2.1 US & Canada Bisphosphonate Drug Sales by Application (2018-2029)
6.2.2 US & Canada Bisphosphonate Drug Revenue by Application (2018-2029)
6.3 US & Canada Bisphosphonate Drug Market Size by Country
6.3.1 US & Canada Bisphosphonate Drug Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Bisphosphonate Drug Sales by Country (2018-2029)
6.3.3 US & Canada Bisphosphonate Drug Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Bisphosphonate Drug Market Size by Type
7.1.1 Europe Bisphosphonate Drug Sales by Type (2018-2029)
7.1.2 Europe Bisphosphonate Drug Revenue by Type (2018-2029)
7.2 Europe Bisphosphonate Drug Market Size by Application
7.2.1 Europe Bisphosphonate Drug Sales by Application (2018-2029)
7.2.2 Europe Bisphosphonate Drug Revenue by Application (2018-2029)
7.3 Europe Bisphosphonate Drug Market Size by Country
7.3.1 Europe Bisphosphonate Drug Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Bisphosphonate Drug Sales by Country (2018-2029)
7.3.3 Europe Bisphosphonate Drug Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Bisphosphonate Drug Market Size
8.1.1 China Bisphosphonate Drug Sales (2018-2029)
8.1.2 China Bisphosphonate Drug Revenue (2018-2029)
8.2 China Bisphosphonate Drug Market Size by Application
8.2.1 China Bisphosphonate Drug Sales by Application (2018-2029)
8.2.2 China Bisphosphonate Drug Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Bisphosphonate Drug Market Size by Type
9.1.1 Asia Bisphosphonate Drug Sales by Type (2018-2029)
9.1.2 Asia Bisphosphonate Drug Revenue by Type (2018-2029)
9.2 Asia Bisphosphonate Drug Market Size by Application
9.2.1 Asia Bisphosphonate Drug Sales by Application (2018-2029)
9.2.2 Asia Bisphosphonate Drug Revenue by Application (2018-2029)
9.3 Asia Bisphosphonate Drug Sales by Region
9.3.1 Asia Bisphosphonate Drug Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Bisphosphonate Drug Revenue by Region (2018-2029)
9.3.3 Asia Bisphosphonate Drug Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Bisphosphonate Drug Market Size by Type
10.1.1 Middle East, Africa and Latin America Bisphosphonate Drug Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Bisphosphonate Drug Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Bisphosphonate Drug Market Size by Application
10.2.1 Middle East, Africa and Latin America Bisphosphonate Drug Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Bisphosphonate Drug Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Bisphosphonate Drug Sales by Country
10.3.1 Middle East, Africa and Latin America Bisphosphonate Drug Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Bisphosphonate Drug Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Bisphosphonate Drug Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Overview
11.1.3 Merck Bisphosphonate Drug Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Merck Bisphosphonate Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 Teva
11.2.1 Teva Company Information
11.2.2 Teva Overview
11.2.3 Teva Bisphosphonate Drug Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Teva Bisphosphonate Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Teva Recent Developments
11.3 Mylan
11.3.1 Mylan Company Information
11.3.2 Mylan Overview
11.3.3 Mylan Bisphosphonate Drug Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Mylan Bisphosphonate Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Mylan Recent Developments
11.4 Apotex Corp
11.4.1 Apotex Corp Company Information
11.4.2 Apotex Corp Overview
11.4.3 Apotex Corp Bisphosphonate Drug Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Apotex Corp Bisphosphonate Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Apotex Corp Recent Developments
11.5 Cobalt Pharmaceuticals
11.5.1 Cobalt Pharmaceuticals Company Information
11.5.2 Cobalt Pharmaceuticals Overview
11.5.3 Cobalt Pharmaceuticals Bisphosphonate Drug Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Cobalt Pharmaceuticals Bisphosphonate Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Cobalt Pharmaceuticals Recent Developments
11.6 Genentech
11.6.1 Genentech Company Information
11.6.2 Genentech Overview
11.6.3 Genentech Bisphosphonate Drug Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Genentech Bisphosphonate Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Genentech Recent Developments
11.7 Novartis Pharmaceuticals
11.7.1 Novartis Pharmaceuticals Company Information
11.7.2 Novartis Pharmaceuticals Overview
11.7.3 Novartis Pharmaceuticals Bisphosphonate Drug Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Novartis Pharmaceuticals Bisphosphonate Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Novartis Pharmaceuticals Recent Developments
11.8 Sanofi-Aventis
11.8.1 Sanofi-Aventis Company Information
11.8.2 Sanofi-Aventis Overview
11.8.3 Sanofi-Aventis Bisphosphonate Drug Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Sanofi-Aventis Bisphosphonate Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sanofi-Aventis Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Bisphosphonate Drug Industry Chain Analysis
12.2 Bisphosphonate Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Bisphosphonate Drug Production Mode & Process
12.4 Bisphosphonate Drug Sales and Marketing
12.4.1 Bisphosphonate Drug Sales Channels
12.4.2 Bisphosphonate Drug Distributors
12.5 Bisphosphonate Drug Customers
13 Market Dynamics
13.1 Bisphosphonate Drug Industry Trends
13.2 Bisphosphonate Drug Market Drivers
13.3 Bisphosphonate Drug Market Challenges
13.4 Bisphosphonate Drug Market Restraints
14 Key Findings in The Global Bisphosphonate Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Merck
Teva
Mylan
Apotex Corp
Cobalt Pharmaceuticals
Genentech
Novartis Pharmaceuticals
Sanofi-Aventis
Ģż
Ģż
*If Applicable.